SCHEMBL7799250

SCHEMBL7799250

COc1cc2nc(N)nc(-c3ccccc3C(F)(F)F)c2cc1OC

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 4/20 0.53
DHFR P00374 1/20 0.46
PTPN1 P18031 5/20 0.46
EGFR P00533 2/20 0.45
CRHR1 P34998 1/20 0.44
WHR1 P49842 1/20 0.44
TRPA1 O75762 1/20 0.44
TRPM8 Q7Z2W7 1/20 0.44
ADRA1D P25100 1/20 0.42
ADRA1A P35348 1/20 0.42
ADRA1B P35368 1/20 0.42
HSP90AA1 P07900 1/20 0.41
HSP90AB1 P08238 1/20 0.41
ADORA1 P30542 1/20 0.40
PDE3B Q13370 1/20 0.40
PDE3A Q14432 1/20 0.40
ATM Q13315 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7791033 0.83 ADORA2A (0.61) ADORA2ADHFREGFRWHR1HSP90AA1
SCHEMBL7799233 0.82 ADORA2A (0.62) ADORA2ADHFREGFRWHR1HSP90AA1
SCHEMBL7800422 0.81 ADORA2A (0.57) ADORA2ADHFREGFRWHR1HSP90AA1
SCHEMBL7585771 0.81 ADORA2A (0.57) ADORA2ADHFREGFRWHR1HSP90AA1
SCHEMBL7790971 0.81 ADORA2A (0.57) ADORA2ADHFREGFRWHR1HSP90AA1
SCHEMBL7791023 0.81 ADORA2A (0.57) ADORA2ADHFREGFRWHR1HSP90AA1
SCHEMBL7799239 0.79 ADORA2A (0.51) ADORA2ADHFREGFRWHR1HSP90AA1
SCHEMBL30759714 0.77 WHR1 (0.71) ADORA2ADHFREGFRWHR1ADORA1
SCHEMBL1257435 0.77 WHR1 (0.71) ADORA2ADHFREGFRWHR1ADORA1
SCHEMBL7800398 0.77 ADORA2A (0.55) ADORA2ADHFRWHR1ADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1162974-A1 QUINAZOLINE FORMULATIONS AND THERAPEUTIC USE THEREOF Parker Hughes Institute (US) 2001-12-19 EP disclosed
WO-2000056338-A1 QUINAZOLINE FORMULATIONS AND THERAPEUTIC USE THEREOF PARKER HUGHES INSTITUTE (US) 2000-09-28 WO disclosed